Quality of Life Improvement Is the Most Important Treatment Goal for Patients With Sickle Cell Disease
Researchers sought to determine what should be the primary treatment goal for patients with sickle cell disease.
Researchers sought to determine what should be the primary treatment goal for patients with sickle cell disease.
Researchers assessed the effect of COVID-19 convalescent plasma on survival benefit at 7 and 14 days for patients hospitalized with the disease.